Insider transactions

EDGAR

VERVE THERAPEUTICS, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

This issuer has insider filings in the store, but no transaction in this window or code group.

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
GV 2017, L.P. Common Stock, par value $0.001 per share0.00.0007/25/2025 Filed 2025-07-28SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-020385 Dispute this row
GV 2017 GP, L.P. Common Stock, par value $0.001 per share0.00.0007/25/2025 Filed 2025-07-28SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-020385 Dispute this row
GV 2017 GP, L.L.C. Common Stock, par value $0.001 per share0.00.0007/25/2025 Filed 2025-07-28SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-020385 Dispute this row
GV 2019, L.P. Common Stock, par value $0.001 per share0.00.0007/25/2025 Filed 2025-07-28SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-020385 Dispute this row
GV 2019 GP, L.P. Common Stock, par value $0.001 per share0.00.0007/25/2025 Filed 2025-07-28SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-020385 Dispute this row
GV 2019 GP, L.L.C. Common Stock, par value $0.001 per share0.00.0007/25/2025 Filed 2025-07-28SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-020385 Dispute this row
GV 2023, L.P. Common Stock, par value $0.001 per share0.00.0007/25/2025 Filed 2025-07-28SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-020385 Dispute this row
GV 2023 GP, L.P. Common Stock, par value $0.001 per share0.00.0007/25/2025 Filed 2025-07-28SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-020385 Dispute this row
GV 2023 GP, L.L.C. Common Stock, par value $0.001 per share0.00.0007/25/2025 Filed 2025-07-28SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-020385 Dispute this row
Alphabet Holdings LLC Common Stock, par value $0.001 per share0.00.0007/25/2025 Filed 2025-07-28SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-020385 Dispute this row
Verily Life Sciences LLC Common Stock, par value $0.001 per share0.00.0007/25/2025 Filed 2025-07-28SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-020385 Dispute this row
XXVI Holdings Inc. Common Stock, par value $0.001 per share0.00.0007/25/2025 Filed 2025-07-28SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-020385 Dispute this row
Alphabet Inc. Common Stock, par value $0.001 per share0.00.0007/25/2025 Filed 2025-07-28SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-020385 Dispute this row
Pentwater Capital Management LP Common Stock, par value $0.001 per share7.56,720,000.0006/30/2025 Filed 2025-08-14SCHEDULE 13GOpen filing 0000902664-25-003639 Dispute this row
Matthew Halbower Common Stock, par value $0.001 per share7.56,720,000.0006/30/2025 Filed 2025-08-14SCHEDULE 13GOpen filing 0000902664-25-003639 Dispute this row
BIOTECHNOLOGY VALUE FUND L P Common Stock, par value $0.001 per share00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000921895-25-002286 Dispute this row
BVF I GP LLC Common Stock, par value $0.001 per share00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000921895-25-002286 Dispute this row
BIOTECHNOLOGY VALUE FUND II LP Common Stock, par value $0.001 per share00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000921895-25-002286 Dispute this row
BVF II GP LLC Common Stock, par value $0.001 per share00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000921895-25-002286 Dispute this row
Biotechnology Value Trading Fund OS LP Common Stock, par value $0.001 per share00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000921895-25-002286 Dispute this row
BVF Partners OS Ltd. Common Stock, par value $0.001 per share00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000921895-25-002286 Dispute this row
BVF GP HOLDINGS LLC Common Stock, par value $0.001 per share00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000921895-25-002286 Dispute this row
BVF PARTNERS L P/IL Common Stock, par value $0.001 per share00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000921895-25-002286 Dispute this row
BVF INC/IL Common Stock, par value $0.001 per share00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000921895-25-002286 Dispute this row
LAMPERT MARK N Common Stock, par value $0.001 per share00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0000921895-25-002286 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,708,462 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015124,844
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to VERVE THERAPEUTICS, INC.